凯立新材(688269) - 凯立新材投资者关系活动记录表2024-0507

Financial Performance - In Q1 2024, the company's net profit was 11.4969 million yuan, a decrease of 7.14% compared to the same period last year [2] - The decline in profit is attributed to a 15.92% decrease in sales volume of homogeneous precious metal catalysts and a 11.74% drop in gross profit margin [2] - Revenue from the basic chemical sector increased to 19.02%, contributing positively to income and profit [2] Revenue Structure - In 2023, the revenue structure was as follows: pharmaceutical sector 59.9%, new chemical materials 16.3%, basic chemicals 13.9%, and pesticides 7.41% [4] - In Q1 2024, the revenue structure shifted to: pharmaceutical sector 46.49%, new chemical materials 21.5%, basic chemicals 19.02%, and pesticides 9.03% [4] Technical Services - The decrease in technical service income is due to the revenue recognition based on project progress, with fewer contracts meeting the recognition criteria in Q1 2024 [3] - The company is actively working on high-performance dehydrogenation platinum-based catalysts, currently in the batch trial production phase [3] Inventory Management - The inventory structure includes raw materials, turnover materials, work-in-progress, and finished goods, with a significant portion being turnover materials [3] - The company is focusing on controlling the quantity of turnover materials and reducing exposure to precious metal price risks [4] Research and Development - Ongoing projects in the hydrogen energy sector include PEM electrolyzer catalysts, new organic liquid hydrogen storage systems, and proton exchange membrane fuel cell catalysts, with several models in market promotion [5]